Identification and analysis of divergent immune gene families within the Tasmanian devil genome by Katrina M. Morris et al.
RESEARCH ARTICLE Open Access
Identification and analysis of divergent
immune gene families within the
Tasmanian devil genome
Katrina M. Morris1, Yuanyuan Cheng1, Wesley Warren2, Anthony T. Papenfuss3,4 and Katherine Belov1*
Abstract
Background: The Tasmanian devil (Sarcophilus harrisii) is being threatened with extinction in the wild by a disease
known as devil facial tumour disease (DFTD). In order to prevent the spread of this disease a thorough
understanding of the Tasmanian devil immune system and its response to the disease is required. In 2011 and 2012
two genome sequencing projects of the Tasmania devil were released. This has provided us with the raw data
required to begin to investigate the Tasmanian devil immunome in depth. In this study we characterise immune
gene families of the Tasmanian devil. We focus on immunoglobulins, T cell receptors and cytokine families.
Results: We identify and describe 119 cytokines including 40 interleukins, 39 chemokines, 8 interferons, 18 tumour
necrosis family cytokines and 14 additional cytokines. Constant regions for immunoglobulins and T cell receptors
were also identified. The repertoire of genes in these families was similar to the opossum, however devil specific
duplications were seen and orthologs to eutherian genes not previously identified in any marsupial were also
identified.
Conclusions: By using multiple data sources as well as targeted search methods, highly divergent genes across the
Tasmanian devil immune system were identified and characterised. This understanding will allow for the
development of devil specific assays and reagents and allow for future studies into the immune response of the
Tasmanian devil immune system to DFTD.
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Background
The Tasmanian devil (Sarcophilus harrisii) is the world’s
largest surviving marsupial carnivore. The devil facial
tumour disease (DFTD) is currently threatening Tasmanian
devils with extinction. Since its emergence around 1996,
the disease has spread rapidly across the state resulting in a
population decline of around 80 % [1]. This had led to
Tasmanian devils being listed as endangered by the Inter-
national Union for Conservation of Nature (IUCN) [2]. An
unusual feature of DFTD is that it is transmitted as an allo-
graft when Tasmanian devils bite each other [3, 4]. This
makes DFTD one of only three naturally occurring clonally
transmissible tumours along with canine transmissible
venereal tumour in dogs [5], and a recently identified trans-
missible cancer in clams [6]. This tumour is able to trans-
mit between unrelated hosts without eliciting an immune
response [7, 8], but how this tumour avoids the host
immune system is not fully understood. The tumour down-
regulates cell surface Major Histocompatibility Complex
(MHC), which allows the tumour to ‘hide’ from the host
immune system [9]. However, these observations do not
fully account for the ability of DFTD to avoid immune rec-
ognition, as a lack of MHC expression should still elicit a
NK cell response [10]. In the past, investigation into the im-
munology of the Tasmanian devil and its immune response
to the tumour has been hampered by a lack of genomic
and immunological resources. Characterisation of immune
gene repertoires is important for the development of spe-
cific immune reagents necessary for vaccine development.
In addition, gene identification and specific reagents are
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required for devil specific assays such as qPCR, immuno-
histochemistry, immunocytochemistry and flow cytometry.
Since 2012 two Tasmanian devil genomes have been avail-
able [11, 12], one of which is available on the Ensembl gen-
ome browser. While many Tasmanian devil genes have
been annotated in the Ensembl pipeline, numerous diver-
gent genes of the immune system were missed by the
Ensembl annotation or have been poorly annotated. Several
families of the Tasmanian devil immune system have been
characterised in previous studies, including natural killer
cell receptors [13], major histocompatibility complex
(MHC; [14, 15]) and toll-like receptors (TLR; [16]). Several
additional divergent immune gene families, important for
characterisation of immune response, have not been inves-
tigated in the Tasmanian devil, including cytokine families,
immunoglobulins and T-cell receptors. Within the marsu-
pials these families have been best characterised in the gray
short-tailed opossum (Monodelphis domestica), for which a
good quality genome assembly is available [17]. Some genes
have also been characterised in additional marsupials
including tammar wallaby (Macropus eugenii), brushtail
possum (Trichosurus vulpecula) and koala (Phascolarctos
cinereus) [18–21]. Research into the marsupials thus far
has demonstrated that the marsupial immunome is
similar to that of eutherian species, although notable
differences occur including marsupial specific expan-
sions within chemokines [22], the absence of IgD [19]
and the presence of a T cell receptor found only in mar-
supials and monotremes [19].
Cytokines are a diverse group of secreted proteins pro-
duced by a broad range of cells that act as mediators of
the immune system. Different cytokine profiles are asso-
ciated with Th1 and Th2 immune responses, and thus
can be used to characterise the immune response to
pathogens [23]. Groups of cytokines include chemo-
kines, interleukins, interferons, tumour necrosis factors
(TNF) and growth factors. Interleukins are a diverse
group of cytokines; in humans there are 36 interleukins
with roles in cell proliferation, maturation, migration
and adhesion [24], while 34 interleukins have been iden-
tified in opossum [22]. Chemokines are involved in
inflammation, cell migration, activation and differenti-
ation [25]. Within the chemokines are four subclasses
defined by their characteristic spacing of cysteine resi-
dues (C, CC, CXC and, CX3C). The chemokine family is
a dynamically evolving family, with some chemokines
being conserved among vertebrates, while lineage spe-
cific duplications of chemokines are seen particularly
within the CC and CXC subclasses [22]. Interferons are
related group of cytokines with a critical role in anti-
viral immune response [26]. Within the interferons are
three subclasses. Type I contains several members in-
cluding IFN-α - β and -κ while the Type II interferon
class has a single member (IFN-γ). In the opossum seven
IFN-α genes have been identified, while single - β, - κ
and -γ are present [22]. Type III interferons are known
as IFN-λ interferons. Tumour necrosis factors are a fam-
ily of cytokines that can elicit apoptosis of cells and in
humans, 19 members of this family have been recog-
nised [27].
There are two antigen receptor systems in vertebrates
that allow for antigen specific binding: immunoglobulins
(Ig) and T cell receptors (TCR). Immunoglobulins,
produced by B cells, are formed by two identical heavy
and light chains with each chain consisting of a constant
and a variable region [28]. Multiple heavy chain constant
regions are encoded in the genome and these determine
the isotype of the immunoglobulin. There are five Ig iso-
types present in mammals, which are defined by their
heavy chain constant region (A, D, G, E, M) and there are
two light chain classes seen in vertebrates (λ and κ) [28].
In the marsupials single A, G, E and M regions have been
identified, as well as single κ and multiple λ domains,
while an ortholog to D has not been identified [29].
T cell receptors allow for recognition of MHC bound
antigens. These receptors are made of two TCR chains.
Like Igs, TCR contain variable regions and constant re-
gions which define the chain class. These chains include
α, β, δ and γ in all studied mammalian species; these
classes may contain single or multiple constant domain
loci [19]. Within the marsupials and monotremes exists
an additional TCR chain, μ, which in studied species has
multiple constant domain loci [30].
Little is known about these genes in marsupials outside
of the opossum. However, the opossum, an American
marsupial, diverged from Australian marsupials about 80
million years ago [31]. Therefore we expect to see differ-
ences in the immune gene repertoires of these two species.
In this study we identify and characterise these divergent
immune gene families within the Tasmanian devil genome
assembly. To aid in immune gene identification and
characterisation we have produced transcriptomes for
Tasmanian devil lymph and spleen.
Results and discussion
We have used multiple data sources and a combination
of search methods to locate divergent Tasmanian devil
immune genes. The data sources include two genomes
[11, 12] and five transcriptomes (testis, tumour [32],
milk, spleen and lymph; see Additional file 1 for acces-
sion numbers). Search methods utilised included basic
local alignment search tool (BLAST) searches, hidden
Markov model (HMMER) searches and searches based
on conserved synteny. We report the identification of
141 Tasmanian devil immune genes including cytokines,
chemokines, Igs and TCRs. All identified sequences have
been deposited into a publicly available database (http://
hp580.angis.org.au/tagbase/gutentag/).
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Interleukins
A total of 40 interleukin genes were predicted from the
Tasmanian devil genome (Table 1; Additional file 2). Of
these 28 were orthologs of human interleukins while the
remaining 11 represented marsupial or devil specific
duplications. These included three homologs of human
IL18 and two genes related to the IL-36 family of genes
in eutherian mammals. IL18 is highly conserved among
most vertebrate lineages, being present as a single copy
in species of fish, birds, reptiles and mammals [33–35].
Although only a single IL18 ortholog was identified in a
previous study on opossums [22] an additional IL18
homolog was identified by the Ensembl annotation
[Ensembl:ENSMODG00000014381] adjacent to the pre-
viously identified IL18. To our knowledge duplication of
the IL18 locus has not been previously reported in any
species. To explore the evolutionary relationships be-
tween mammalian IL-18 sequences a phylogeny was
constructed (Fig. 1). The single identified wallaby IL-18
forms an orthologous relationship to one of the devil
and opossum IL-18 sequences. The second opossum
sequence appears to be orthologous to a second devil se-
quence, while the third devil sequence has no clear
orthologue. This indicates that the duplication of IL18
may have occurred early on marsupial evolution rather
than representing lineage specific duplications within
marsupial lineages. Only one of the copies of IL18 was
expressed in the available Tasmanian devil transcrip-
tomes (IL18A; expressed in testis, tumour and milk tran-
scriptomes; Additional file 3) so it has yet to be seen
whether the additional copies are expressed.
A full length IL22 gene was identified in the Tasman-
ian devil genome. This gene had five exons, as in the hu-
man IL22. However, an additional five partial genes or
gene fragments were identified, representing at least
three unique IL22-like loci. An alignment of all the
Tasmanian devil IL-22 sequences identified is shown in
Additional file 4. These gene fragments were all identi-
fied in short or highly fragmented contigs, therefore
these fragments may be part of full IL22 sequences.
Some of the fragments identified could potentially be
part of the same gene, for example the sequences
IL22F3, - F4, and -F5 could combine to encode a full
IL22 sequence. One of the IL22 sequences (IL22F1) had
no introns, and therefore is likely to be a processed
pseudogene. A processed pseudogene is produced from
the reverse transcription of an mRNA transcript with
subsequent reintegration into chromosomal DNA [36].
Interestingly, this sequence shows higher identity to the
IL22F3 and IL22F4 fragments (both sequences with
introns), than the IL22 sequence. Therefore the IL22F1
sequence more likely was generated from the transcript
of one (or both) of these sequences than from the IL22
sequence. This provides further evidence that there is
Table 1 Summary table of cytokine, immunoglobulin and T-cell
receptor sequences identified in Tasmanian devil
Interleukins Chemokines TNF family Ig constant
regions
IL10 CC family TNF A
IL11 CCL26 LTA G
IL12A CCLD1a LTB E
IL12B CCLD2a TNFSF4 M
IL13 CCLD3a CD40LG K
IL15 CCLD4a FASLG L1a
IL16 CCLD5a CD70 L2a
IL17A CCLD6a TNFSF8 L3a
IL17B CCLD7a TNFSF9 L4a
IL17C CCLD8a TNFSF10
IL17D CCLD9a TNFSF10L TCR constant
regions
IL17F CCLD10a TNFSF11 TRGC
IL18Aa CCLD11a TNFSF13La TRAC
IL18Ba CCLD12a TNFSF13B TRDC
IL18Ca CCLD13a TNFSF14 TRBC1a
IL19 CCLD14a TNFSF15 TRBC2a
IL1A CCLD15a TNFSF18 TRBC3a
IL1B CCLD16a EDA TRMC1a
IL1F10 CCL17 TRMC2a
IL1RN CCL19 Interferons TRMC3a
IL2 CCL20 IFNA1a TRMC4a
IL20 CCL21 IFNA2a TRMC5a
IL21 CCL22 IFNA3a TRMC6a




IL22F4a CXC family IFNL2a
IL22F5a CXCLD1a











IL5 XC family TGFB1
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more than one full length IL22 gene in the Tasmanian
devil genome. In most species, including opossum, IL22
is represented by a single sequence [22]. However, a
duplication at the locus is seen in some strains of mice
[37]. None of the Tasmanian devil IL22 sequences were
identified in the devil transcriptomes. Further investiga-
tion will be required to determine whether the Tasmanian
devil may have more than one functional IL22 gene.
Orthologs of the genes IL3, IL32 and IL37 were not
identified. Orthologs to IL32 and IL37 have not, to
our knowledge, been identified to any animal outside
of eutherian mammals, including both opossum and
wallaby [22]. Therefore it is likely that these two in-
terleukins are specific to eutherian mammals. As in
the opossum [22], IL3 could not be identified in the
Tasmanian devil genome, despite being present in
both eutherian mammals and chicken. The syntenic
region in the Tasmanian devil genome was searched,
but as in opossum, this region was fragmented, so it
is possible that this gene could not be identified due
to this fragmentation. In total 13 of the 40 interleukin
sequences were identified in one or more Tasmanian
devil transcriptomes, with IL16 being the most ubi-
quitously expressed, being expressed in all five tran-
scriptomes (Additional file 3).
Chemokines
Thirty-nine chemokines were identified in the Tasmanian
devil genome (Table 1; Additional file 5). This is greater
than that identified in the opossum (36) and the chicken
(24), but less than the human (47) [22, 38]. Twenty-four
chemokines of the CC family were identified, including
orthologs to ten eutherian CCL chemokines (Fig. 2).
Genes CCLD5-CCLD10 appear to form a devil specific ex-
pansion (Fig. 2), and are likely to have duplicated recently
due to their high identity (93.4–97.8 % amino acid iden-
tity) and their proximity to each other in the Tasmanian
devil genome (See Additional file 5). These sequences lack
direct orthology even to opossum sequences, and appear
to be related to the human CCL4 family. In addition, two
pseudogenes related to this group were also identified in
the Tasmanian devil genome, with either frame shifts or
early stop codons. One CCL chemokine not identified,
despite being identified in the opossum genome was
CCL5. This gene could not be located by BLAST or
HMMER searches in either the genome or in the tran-
scriptomes. The genomic region syntenic to the opossum
region containing CCL5 was fragmented in the Tasmanian
devil genome which may explain why this gene cannot be
located. CCL16 was not identified in devil or opossum,
and this gene appears to be present only in the eutherian
lineage. CCL6, 9, and 12 were also not found, but these
genes have thus far only been identified in rodents. A large
number of CCL chemokines, in total thirteen, were identi-
fied in the transcriptomes (See Additional file 3). CCLD14,
a chemokine with no identified orthologue in opossum or
eutherians, was the most ubiquitously expressed being
identified in all five of the transcriptomes.
Twelve CXC chemokines were identified in the
Tasmanian devil genome, nine of which were identified
Table 1 Summary table of cytokine, immunoglobulin and T-cell
receptor sequences identified in Tasmanian devil (Continued)
IL6 XCLAa TGFB2
IL7 XCLBa TGFB3
IL8 CX3C family VEGFA
IL9 CX3CL1
aindicates a gene which is not a direct ortholog of a eutherian gene
Fig. 1 Phylogeny of IL18 amino acid sequences. Maximum likelihood tree of IL18 amino acid sequence with 1000 bootstrap resamplings,
including devil (red), wallaby (gray), opossum (yellow), platypus (black), human (blue), mouse (cyan) and chicken (green) sequences. Bootstrap value
greater than 50 % only are displayed. There are three sequences (Devil A, B and C) in the Tasmanian devil and two (Opossum A and B) in the
opossum due to duplications in the genome of these species
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in the devil transcriptomes (Additional file 3). Eight of
these are orthologs of eutherian chemokines (Fig. 3).
Interestingly, while CXCL10 is represented by a single
gene in all species to our knowledge, two CXCL10 ho-
mologs were identified in the Tasmanian devil genome,
located adjacent to one another in the devil genome.
While CXCL10A appears to be an ortholog to the opos-
sum CXCL10 with strong bootstrap support, CXCL10B
is more divergent (Fig. 3). The two Tasmanian devil
genes were quite divergent (only 38 % amino acid iden-
tity) but both retained conserved CXC family residues
including the cysteine residues, and so it is possible that
both are functional. Only CXCL10A however, was
expressed in a transcriptome (milk) so it is yet to be seen
whether CXCL10B is also transcribed.
As in opossum and human, two XC chemokines are
present in the Tasmanian devil genome, but these are
not orthologous to either the human chemokines or the
opossum (Additional file 6). Therefore, the duplication
of an ancestral XCL gene likely occurred independently
in the three lineages. The CX3C chemokine family is
represented by a single gene in all species studied, and a
single ortholog was identified in the Tasmanian devil
genome.
Interferons
Type I interferons in mammals include α, β, δ, ε, ω and κ
interferons. In the opossum only α, β and κ type inter-
ferons have been identified [19]. In the Tasmanian devil an
ortholog to the human and opossum IFNB was identified
(Table 1; Additional file 7; Fig. 4). Mammalian species typ-
ically have multiple IFNA loci; humans have thirteen while
in the opossum seven have been identified [22]. Only four
IFNAs could be identified in the Tasmanian devil genome.
However in addition, two IFNA pseudogenes were identi-
fied with early stop codons. These may represent recent
loss of α interferon sequences, partly accounting for the
difference in number between opossum and devil. In a
Fig. 2 Phylogeny of CC family chemokine amino acid sequences from devil, opossum and human. Maximum likelihood tree with 1000 bootstrap
resamplings. Bootstrap value greater than 50 % only are displayed. Devil, opossum and human sequences are indicated by red, yellow and blue
dots respectively
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phylogeny of interferons including human, mouse, devil
and opossum (Fig. 4) IFNA genes formed species specific
clades, suggesting that these genes evolve rapidly in both
eutherian and marsupial species. IFNK could not be iden-
tified in either Tasmanian devil genome assembly, nor
could it be identified in transcriptomes. The genes that
occur upstream and downstream of IFNK in the opossum
were identified in the Tasmanian devil genome, but these
were at the ends of supercontigs, so it is likely that this
gene is missing from the devil genome assembly. As in
other marsupials, sequences encoding interferons δ, ε and
ω were not identified in the Tasmanian devil genome.
Type II interferons are represented by a single gene in
most species, IFNG. An ortholog to this gene was identi-
fied in the Tasmanian devil genome. The type III inter-
ferons group consists of IFN-λ molecules, in humans
these are encoded by IFNL1-3, also known as IL29,
IL28A and IL28B. Two IFNL genes were identified in the
Tasmanian devil genome. These were not orthologous to
the eutherian IL28A/B or IL29 genes, but appear to be a
marsupial specific duplication (Fig. 4). No interferon was
expressed in any of the Tasmanian devil transcriptomes
(Additional file 3).
Tumour necrosis factors
Eighteen TNF family members were identified in the
Tasmanian devil genome (Table 1; Additional file 8) nine
of which were expressed in a devil transcriptome. Ortho-
logs to most human members of the TNF family were
identified in the Tasmanian devil genome. A single
sequence (named TNSF13L) that showed homology to
both TNFSF12 and TNFSF13 was identified in the
Tasmanian devil. TNFSF18 has not been previously pre-
dicted in any marsupials, though is present in both
eutherians and platypus. Devil TNFSF18 could not be
identified using BLAST or HMMER searches, but was
identified based on the conserved synteny of the region.
TNFSF18 was highly divergent from eutherian orthologs,
with only 17 % amino acid identity between Tasmanian
devil and human sequences, accounting for the difficulty
Fig. 3 Phylogeny of CXC family chemokine amino acid sequences from devil, opossum and human. Maximum likelihood tree with 1000
bootstrap resamplings. Bootstrap value greater than 50 % only are displayed. Devil, opossum and human sequences are indicated by red, yellow
and blue dots respectively
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in predicting this gene. TNFSF10L, a gene present in
fish, birds and monotremes, but not in eutherian mam-
mals, was also identified in the Tasmanian devil genome.
In opossum, the FASLG sequence contained a frame
shift mutation and its receptor FAS could not be identi-
fied, despite using the same search strategies used in the
current study, leading to speculation that this ligand and
receptor may not be functional in the opossum [22].
However, FASLG was identified in the Tasmanian devil
genome without any features to suggest that it is a
pseudogene and FAS was also identified. In addition
both FASLG and FAS were expressed in the Tasmanian
devil milk transcriptome, thus these proteins are likely
to be functional in the devil.
Two TNF family genes (TNFSF10 and TNFSF11) were
difficult to predict in the Tasmanian devil genome due
to exons being present on more than one scaffold, and
being only partly present in either of the two genome
assemblies. This indicates that the regions containing
these genes may contain repetitive elements making
them difficult to assemble. This also highlighted errors
in the Ensembl 7.1 assembly; while the majority of the
TNFSF11 sequence was identified on a scaffold
GL849887.1 flanked by two other genes, the first half of
exon 1 was located on scaffold GL864876.1, within the
intron of another gene. In addition the last exon was
located on a third scaffold, GL851272.1. This arrange-
ment is highly unlikely to represent the actual genomic
arrangement and is likely the result of an error in the
assembly.
Additional cytokines
Fourteen additional cytokines not belonging to one of
the above families were searched for, including the
colony-stimulating factors and the transforming growth
factor families (Table 1; Additional file 9). Orthologs to
all of these genes were located in the Tasmanian devil
genome, including CNTF which has not been previously
predicted in marsupials. Several of these were highly
divergent from their human and even opossum ortho-
logs, including CSF2 and OSM, and these were located
using a combination of HMMER searches, synteny
Fig. 4 Phylogeny of interferon amino acid sequences from devil, opossum, human, mouse and chicken. Maximum likelihood tree with 1000
bootstrap resamplings. Bootstrap value greater than 50 % only are displayed. Devil, opossum, human, mouse and chicken sequences are
indicated by red, yellow, blue, cyan and green dots respectively. Mammalian IFNB, IFNG and IFNK form single clades
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searches and FGENESH+ to predict the genes in the lo-
cations likely to contain the genes. OSM was one of the
most divergent cytokines found in the Tasmanian devil
with only 19 % peptide identity to the human sequence
and 23 % to the predicted sequence in opossum.
Immunoglobulins constant regions
In the Tasmanian devil genome A, E, G and M heavy
chain constant regions were identified (Table 1; Additional
file 10). As with the other marsupial species, such as wal-
laby and possum, that have been studied, the D locus
could not be identified [19]. It is likely that this region has
been lost in all marsupials. While G and A are often repre-
sented by multiple constant domain loci in eutherian
mammals, as in other marsupials studied [19], these are
only represented by single loci in the Tasmanian devil.
The A, E and G loci were located adjacent to one another
on a single scaffold while M was located on another scaf-
fold. All four heavy chain loci were expressed in both the
lymph and milk transcriptomes.
As in most other species the κ light chain is repre-
sented by a single locus in the Tasmanian devil genome.
Four λ constant chains were identified compared to
eight in the opossum [29]. The K and L loci were all
located on separate scaffolds in the Tasmanian devil gen-
ome, indicating that this region is highly fragmented.
Due to this it is possible that there may be additional L
loci in the Tasmanian devil genome that could not be
identified due to fragmentation. The κ and a single λ
chain (λ4) were expressed in both the lymph and milk
transcriptomes (Additional file 3). Therefore it is pos-
sible that in the Tasmanian devil light chain expression
is dominated by single κ and λ light chains.
T cell receptors
T cell receptor constant domains were also identified in
the Tasmanian devil genome (Table 1; Additional file 11).
Within most vertebrate mammals there are four TCR
constant domains; α and δ which are typically found at
the same locus, and β and γ which form unique genomic
loci [19]. These are commonly represented by a single
constant domain, except for β which is usually duplicated.
Marsupials and monotremes have an additional TCR
locus, the M locus, which contains multiple μ constant
domains [19]. Constant domains from these five loci were
identified in the Tasmanian devil genome. As with other
mammals, the α and δ constant domains were found in
close proximity, on contig GL834496.1. Three β domains
were identified, compared to four which have been identi-
fied in opossum [39]. The single γ constant domain was
also identified. A total of six μ constant domains were
identified compared to eight in the opossum [39]. How-
ever, these were spread across five contigs in the Tasmanian
devil genome, with most of these contigs being short and/
or fragmented, so it is possible that additional domains exist
that could not be identified due to fragmentation of the
genome assembly. Heterodimers are formed by the α and β
chains, and the δ and γ chains; in humans 95 % of TCR
expression is composed of the α/β heterodimer [40].
Within the lymph node transcriptome α and β transcripts
(TRBC1) were expressed, but not δ and γ, indicating that
the α/β heterodimer may also dominate in the Tasmanian
devil. Within the milk transcriptome TRGC and an add-
itional β (TRBC2) were also identified. In addition μ chains
were identified in both the lymph (TRMC4) and milk
(TRMC4, TRMC2, TRMC6) transcriptomes. While variable
domains for both the Igs and TCRs were identified, due to
the highly fragmented nature of these regions it is highly
likely that a large number of variable domains are missing
from the genome and determining the genomic arrange-
ment is not possible with the current genome assembly.
With additional work to improve assembly of these regions
in the Tasmanian devil genome this will be possible in the
future.
Genome limitations
A recurring problem with gene identification was the
fragmentation of the genome assembly in the regions
containing genes of interest. In some cases only partial
genes could be predicted, with the predicted location of
exons being beyond the end of the scaffold or in a break
in the scaffold. Additionally, entire genes could not be
located, but their predicted location was between two
genomic scaffolds. Within highly duplicated groups of
genes that are predicted to occur in the same genomic
locus, such as the TRMC genes or CCL genes, fragmen-
tation of these regions means that family members may
be missing from the genome assemblies, and due to this
we cannot definitively determine the number of se-
quences within these families in this study. While frag-
mentation was also an issue in identifying sequences in
the opossum genome [22], the opossum genome gener-
ally has better coverage in these regions. For example
the majority of CCL genes in the opossum could be
identified in a single scaffold [22], while the majority of
these in Tasmanian devil were found individually on
unique scaffolds. This fragmentation makes examining
genomic synteny on a wide scale difficult. Despite the is-
sues with fragmentation, the vast majority of genes
searched for in the Tasmanian devil genome were identi-
fied in this study. Additionally, access to two genome as-
semblies was beneficial for identifying genes in this
study. The Murchison et al. [12] assembly, present on
Ensembl, was the main genome used for gene identifica-
tion as the scaffold length is generally much higher.
However, genes missing, or partially missing from this
assembly were located in the Miller et al. [11] assembly,
including CXCL16, TNFSF10, TNFSF11.
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Conclusions
The availability of genomic and transcriptomic data has
enabled us to investigate a broad range of immune genes
for the first time in an Australian marsupial. Through
the use of genomes and transcriptomes, diverse genes
encoding critical components of the immune response
can be identified and characterised, paving the way for
future research into the immunology and diversity of the
species. This is expected to be an increasingly important
approach for research and conservation of threatened
and endangered species in the future.
In this study a total of 141 immune genes were identi-
fied in the Tasmanian devil genome. While many of
these were annotated in the Ensembl pipeline, 30 % of
the genes searched for were either missed by the
Ensembl annotation, or were poorly or partially anno-
tated, particularly genes that are highly divergent from
marsupial and eutherian orthologs. By using multiple
data sources as well as targeted search methods, highly
divergent genes were identified. In general, orthologs
that were expected to be present in the Tasmanian devil
genome were identified. Several eutherian genes that
have not been previously identified in marsupials were
also not identified in the Tasmanian devil, providing fur-
ther evidence that these genes are likely to have either
evolved within the eutherian lineage (including CCL6,
CCL16, IL32 and IL37) or have been deleted in the mar-
supial lineage (such as the IgD locus). A small number
of genes that were expected to be present in the
Tasmanian devil genome, including IFNK and CCL5,
could not be identified by any method. The predicted lo-
cations of these genes are in fragmented regions of the
genome assembly, and their absence from the transcrip-
tomes is not unexpected. Therefore, it is more likely that
these are missing from the genome assembly and not
expressed in the transcriptomes, rather than being ab-
sent from the Tasmanian devil genome. Several genes
that have not been previously identified in any marsupial
species were identified in this study including IL23A,
TNFSF18 and CNTF.
Genes that formed devil or marsupial specific expan-
sions were identified in the CXC and CC chemokine
families and in the interferon α family. Expansions in
these families have been previously seen in the opossum
[19]. In the CC family, five CCL genes represent a
lineage specific expansion in the devil. In addition, sev-
eral unexpected duplications were seen in the Tasmanian
devil genome. This included duplication of the IL18,
IL22 and CXCL10 genes. In the future it would be inter-
esting to determine whether more than one of these du-
plicated loci is functional.
Discovery of these genes is the essential first step to
many research projects in the Tasmanian devil. This in-
cludes the development of antibodies, such as anti-devil
IgG or anti-devil CD8, which allow for detailed im-
munological research of the devil and of DFTD, and for
vaccine development [8, 41]. Identification of devil gene
sequences are the first step for development of assays in-
cluding qPCR, ELISA, immunohistochemistry and flow
cytometry. These assays are crucial for investigating dis-
ease pathology and immune response in Tasmanian
devils [8, 42, 43]. Genes described in this paper can be
used to develop antibodies against Th1 and Th2 cyto-
kines to further characterise devils’ response to DFTD.
In addition, discovery of these genes is essential for look-
ing at genetic variation at these immune genes that
could correlate to DFTD resistance and could vary
across populations in the wild. Tasmanian devils have a
lack of genetic diversity which is believed to have made the
Tasmanian devil susceptible to disease outbreaks [14, 44].
Any variation in these genes, particularly functional vari-
ation, will be essential to maintain both in the wild and in
captivity. Targeted assays are now being developed to moni-
tor genetic diversity in these genes both in the wild and
captivity [45, 46]. With further research into the Tasmanian
devil immune system and its response to DFTD, develop-
ment of a vaccine or treatment for DFTD may be possible
in the near future.
Methods
Sample collection, RNA extraction and cDNA library
preparation
Tasmanian devil tissue samples were collected under
Animal Ethics permits DPIPWE AEC No. 21/2007-08.
Spleen and lymph node RNA was extracted from frozen
tissue samples (n = 1 per tissue) using QIAGEN RNeasy
Plus Micro Kit. The concentration of extracted RNA
was measured on a NanoDrop (spleen 54 ng/ul, A260/
A280 2.00; lymph node 32 ng/ul, A260/A280 1.84) and
the quality was checked by visualising on a denaturing
TAE gel. Double-stranded cDNA libraries were synthe-
sized using Evrogen MINT cDNA synthesis kit, normal-
ised with Evrogen TRIMMER cDNA normalization kit,
and amplified using Clontech Advantage 2 PCR kit.
Transcriptome sequencing and assembly
Each cDNA library was sequenced on a Roche 454 se-
quencer using manufacturer’s protocols. For the spleen
and lymph node libraries 528,254 and 488,351 reads
were obtained respectively. Reads were assembled using
Newbler which generated 13,314 and 7544 contigs with
an average base length of 869 and 794, (500 bp cutoff )
for the spleen and lymph node respectively. The average
coverage of contigs longer than 100 nt was 16.2X and
49.4X for spleen and lymph node respectively. Reads
were submitted to the European Nucleotide Archive
(spleen; [ERA:ERS624952], lymph node [ERA:ERS624953]).
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Gene identification
Tasmanian devil immune genes were identified with a
variety of approaches in the two Tasmanian devil ge-
nomes (DEVIL7.0, [GenBank:GCA_000189315.1], [12];
[GenBank:GCA_000219685.1], [11]) as well the available
Tasmanian devil transcriptomes; tumour and testis ([SR
A:SRX015790], [SRA: SRX015793], [28]), milk ([SRA:
SRX862745]), and spleen and lymph node. The devil
reference genome [12] was the genome primarily used in
this study as it is available on Ensembl and has better
coverage and higher scaffold lengths. The second gen-
ome assembly [10] was used as a supplement when entire
gene sequences could not been found in the former.
Genes were identified in the Ensembl annotation
(Ensembl release 76) of the Tasmanian devil genome
where well annotated by Ensembl’s automatic annotation.
Unannotated genes, or genes for which the Ensembl an-
notation was poor or partial, were identified by TBLASTN
[47] searches to the Tasmanian devil genome using the
relevant sequence in opossum or wallaby from the immu-
nome database for marsupials and monotremes (IDMM;
http://hp580.angis.org.au/tagbase/gutentag; [48]), or the
relevant human sequences from UniProt when not avail-
able in marsupials. In addition, HMMER [49] searches
were used to identify genes in families likely to have ex-
pansions. To do this, profile hidden Markov models
(HMM) were constructed using relevant family mem-
bers in opossum, human, mouse and chicken. The 6-
frame translation of the Tasmanian devil genome was
then searched using the constructed profile HMM
using HMMER v3.0. This method was used for CXC
and CCL chemokines, Type I interferons, IFNK,
TNFSF18, CSF2 and OSM.
For genes not identified by the above methods,
TBLASTN (E value cut off of 0.1) searches were per-
formed using opossum or wallaby sequences obtained
from IDMM, against the available Tasmanian devil tran-
scriptomes, and the best hits were used as queries to
BLAST the Tasmanian devil genome to determine their
genomic location. When none of the above methods were
successful in identifying orthologs, synteny searches were
performed whereby flanking genes of the opossum ortho-
log were identified. The position of these flanking genes
was determined in the Tasmanian devil genome (either
through the Ensembl annotation of appropriate BLAST
searches) and gene prediction performed using FGE-
NESH+ [50] in the sequence spanning the flanking
genes using the opossum ortholog as an input.
Gene analysis
To confirm their identity, predicted proteins were used as
queries in BLASTP (E value cut off of 10) against SWIS-
SPROT. Additionally, identity was confirmed through se-
quence alignment to orthologs, conservation of protein
domains, presence of conserved and characteristic pro-
tein features and gene structure comparison. Predicted
Tasmanian devil sequences were used to search the avail-
able Tasmanian devil transcriptomes using TBLASTX.
Alignments were produced in BioEdit [51] using the Clus-
talW algorithm [52]. Sequence identity was calculated
using BioEdit where full sequence orthologs were available
for either opossum or human. For phylogenetic tree con-
struction protein sequences were aligned using MUSCLE
[53] through the software package MEGA6 [54], using
default parameters. Only full-length Tasmanian devil se-
quences were included in phylogenies. Phylogenetic trees
were constructed using the maximum-likelihood method
and the Jones-Thorton-Taylor (JTT) model [55], and
evaluation through 1000 bootstrap resamplings in
MEGA6. Accession numbers of sequences used in these
phylogenies can be found in Additional file 1 with the ex-
ception of opossum sequences for Figs. 2, 3, 4 and Add-
itional file 3 which were obtained from IDMM (http://
hp580.angis.org.au/tagbase/gutentag/).
Availability of supporting data
The data sets supporting the results of the article are avail-
able in the [European Nucleotide Archive] repository;
spleen [ERA:ERS624952] and lymph [ERA:ERS624953],
and the Immunome Database for Monotremes and Mar-
supials [http://hp580.angis.org.au/tagbase/gutentag/].
Additional files
Additional file 1: Accession numbers for all data used in this study.
Description of data: Table including accession numbers for the
genomes, transcriptomes and sequences used in phylogenies in
this study. (CSV 3 kb)
Additional file 2: Interleukin sequences identified in the Tasmanian
devil genome. Description of data: Md % = percent amino acid identity
to opossum (Monodelphis domestica) ortholog, Hs % = percent amino
acid identity to Homo sapiens ortholog. * indicates a gene which is not a
direct ortholog of a eutherian gene, ** = partial Ensembl prediction.
(CSV 3 kb)
Additional file 3: Presence of Tasmanian devil sequences identified
in this study in the devil transcriptomes. (CSV 957 bytes)
Additional file 4: Alignment of devil, opossum and human IL22
amino acid sequences. Description of data: Amino acid alignment of
devil IL22 and IL22 fragments to opossum and human IL22 sequences.
Devil sequences IL22F1-IL22F5 are fragments of IL22 identified in frag-
mented regions of the devil genome. (TIF 14687 kb)
Additional file 5: Chemokine sequences identified in the Tasmanian
devil genome. Description of data: Md % = percent amino acid identity
to opossum (Monodelphis domestica) ortholog, Hs % = percent amino
acid identity to Homo sapiens ortholog. * indicates a gene which is not a
direct ortholog of a eutherian gene, ** = partial Ensembl prediction.
(CSV 3 kb)
Additional file 6: Phylogeny of XC family chemokines from devil,
opossum and human. Description of data: XC family chemokines
phylogeny from devil, opossum and human amino acid sequences.
Maximum likelihood tree with 1000 bootstrap resamplings. Bootstrap
value greater than 50 % only are displayed. Devil CCL17 is used as an
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outgroup. Devil, opossum and human sequences are indicated by red,
pink and blue dots respectively. (TIF 1658 kb)
Additional file 7: Interferon sequences identified in the Tasmanian
devil genome. Description of data: Md % = percent amino acid identity
to opossum (Monodelphis domestica) ortholog, Hs % = percent amino
acid identity to Homo sapiens ortholog. * indicates a gene which is not a
direct ortholog of a eutherian gene, ** = partial Ensembl prediction.
(CSV 564 bytes)
Additional file 8: TNF family sequences identified in the devil
genome. Description of data: Md % = percent amino acid identity to
opossum (Monodelphis domestica) ortholog, Hs % = percent amino acid
identity to Homo sapiens ortholog. * indicates a gene which is not a
direct ortholog of a eutherian gene, ** = partial Ensembl prediction.
(CSV 1 kb)
Additional file 9: Additional cytokine sequences identified in the
Tasmanian devil genome. Description of data: Md % = percent amino
acid identity to opossum (Monodelphis domestica) ortholog, Hs % =
percent amino acid identity to Homo sapiens ortholog. * = partial
Ensembl prediction. (CSV 1 kb)
Additional file 10: Immunoglobulin heavy and light chain constant
regions identified in the Tasmanian devil genome. Description of
data: Md % = percent amino acid identity to opossum (Monodelphis
domestica) ortholog, Hs % = percent amino acid identity to Homo sapiens
ortholog. * = partial Ensembl prediction. (CSV 599 bytes)
Additional file 11: TCR constant regions identified in the
Tasmanian devil genome. Description of data: Md % = percent amino
acid identity to opossum (Monodelphis domestica) ortholog, Hs % =
percent amino acid identity to Homo sapiens ortholog. * = partial
Ensembl prediction. (CSV 864 bytes)
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